Historical record - last NADAC effective date: 5/22/2024
Product Information
PREGABALIN 150 MG CAPSULE is a generic product labeled by Cipla USA Inc., priced at $0.0550 per EA under NDC 69097095805. Its NADAC has been published 250 times since Aug 21, 2019.
FDA first approved this application on Jul 19, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Cipla USA Inc.NDC
69097095805
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
5/22/2024
Active Ingredients
PREGABALINApproval Type
Generic (ANDA)
FDA Application
ANDA211384FDA Approved
7/19/2019
TE Code
AB
On Market Since
7/19/2019
Price Statistics
The NADAC for PREGABALIN 150 MG CAPSULE has been published 250 times since Aug 21, 2019, and over the history we have for it it has declined 70.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0550 per EA |
|---|---|
| All-time high | $0.1892 (Sep 11, 2019) |
| All-time low | $0.0550 (May 22, 2024) |
| Median price | $0.0979 |
| Average price | $0.1088 |
| Largest weekly change | -18.7% (Apr 17, 2024) |
| Weeks tracked | 250 |
| Tracking since | Aug 21, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-31.3%
5Y
-47.1%
All
-70.9%
Last surveyed May 29, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PREGABALIN 150 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PREGABALIN 150 MG CAPSULE, manufactured by Cipla USA Inc., is $0.0550 per EA (NDC 69097095805), effective May 29, 2024.
How has the price of PREGABALIN 150 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PREGABALIN 150 MG CAPSULE has declined 70.9%. It has been tracked across 250 weekly CMS publications since Aug 21, 2019.
What are the highest and lowest recorded NADAC prices for PREGABALIN 150 MG CAPSULE?
Since Aug 21, 2019, the NADAC for PREGABALIN 150 MG CAPSULE has ranged from a low of $0.0550 (May 22, 2024) to a high of $0.1892 (Sep 11, 2019), with a median of $0.0979 per EA.
Are there cheaper alternatives to PREGABALIN 150 MG CAPSULE?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PREGABALIN 150 MG CAPSULE, is $0.0510 per EA — about 7% below PREGABALIN 150 MG CAPSULE.
Who manufactures PREGABALIN 150 MG CAPSULE?
PREGABALIN 150 MG CAPSULE (NDC 69097095805) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.